Osteoporosis is a 'silent' progressive and debilitating disease characterized by bone loss, thinning cortical bone and disorganized trabecular bone leading to bone fragility and fracture. Osteoporosis results when the processes of bone formation and bone resorption become uncoupled and the rate of bone resorption becomes much greater than that of bone formation. FDA-approved pharmaceutical interventions have antiresorptiive properties. Some of these drugs have serious side effects. Fluoride (F) therapy as sodium fluoride is the only one shown to consistently increase bone mass, but was also reported to increase fracture risk. The goal of the proposed research is to develop novel materials incorporating magnesium (Mg), zinc (Zn), F ions in a calcium (Ca) phosphate system (Mg/Zn/F-BCP). Separately, these ions have been associated with bone formation, biomineralization and osteoporosis therapy.
Specific aims are to: (1) prepare and characterize the crystallographic, morphologic, and chemical properties of a series of Mg/Zn/F-BCP materials; (2) determine the short and long term initial dissolution rates and release of Ca, Mg, Zn, P and F ions of the materials prepared in Aim 1; (3) determine in vitro response of bone forming (osteoblasts) and bone resorbing (osteoclasts) cells to Mg/Zn/F-BCPs of various compositions using human osteoblast-like cells and rat osteoclast-like cells; (4) determine the effect of orally administered various Mg/Zn/F-BCPs on (a) bone properties (mechanical strength, density, quality, composition, and histomorphometric parameters and bone mineral (crystallinity, composition and dissolution) of adult and aged female and male rats; and (b) on the development of osteoporosis (deficient-diet induced) in adult rats; and (5) determine therapeutic effect of various injected Mg/Zn/F-BCPs on ovariectomized rats using biomechanical, histomorphometric measurements and chemical analyses on bone and plasma analyses. Hypothesis: Biomaterials with Zn, Mg and F ions in a calcium phosphate matrix (used as dietary supplement and ion releasing injectible 'implants') will improve bone health.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Research Project (R01)
Project #
5R01EB003070-03
Application #
6930401
Study Section
Special Emphasis Panel (ZRG1-SSS-M (55))
Program Officer
Moy, Peter
Project Start
2003-09-30
Project End
2007-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
3
Fiscal Year
2005
Total Cost
$500,474
Indirect Cost
Name
New York University
Department
Dentistry
Type
Schools of Dentistry
DUNS #
041968306
City
New York
State
NY
Country
United States
Zip Code
10012
Mijares, Dindo; Kulkarni, Anupama; Lewis, Kanthi et al. (2012) Oral bone loss induced by mineral deficiency in a rat model: effect of a synthetic bone mineral (SBM) preparation. Arch Oral Biol 57:1264-73
Li, Xia; Ito, Atsuo; Sogo, Yu et al. (2009) Solubility of Mg-containing beta-tricalcium phosphate at 25 degrees C. Acta Biomater 5:508-17
Tokudome, Yoshihiro; Otsuka, Makoto; Ito, Atsuo et al. (2009) Long-term therapeutic effect of novel calcium phosphate-based compounds injected in ovariectomized rats. J Biomed Mater Res B Appl Biomater 90:229-37
Li, Xia; Sogo, Yu; Ito, Atsuo et al. (2009) The optimum zinc content in set calcium phosphate cement for promoting bone formation in vivo. Mater Sci Eng C Mater Biol Appl 29:969-975
Yamada, Yasutaka; Ito, Astuo; Kojima, Hiroko et al. (2008) Inhibitory effect of Zn2+ in zinc-containing beta-tricalcium phosphate on resorbing activity of mature osteoclasts. J Biomed Mater Res A 84:344-52
Otsuka, Makoto; Oshinbe, Ayako; Legeros, Racquel Z et al. (2008) Efficacy of the injectable calcium phosphate ceramics suspensions containing magnesium, zinc and fluoride on the bone mineral deficiency in ovariectomized rats. J Pharm Sci 97:421-32
Sogo, Yu; Ito, Atsuo; Yokoyama, Daiki et al. (2007) Synthesis of fluoride-releasing carbonate apatites for bone substitutes. J Mater Sci Mater Med 18:1001-7
Ito, Atsuo; Senda, Koji; Sogo, Yu et al. (2006) Dissolution rate of zinc-containing beta-tricalcium phosphate ceramics. Biomed Mater 1:134-9